ETON - Eton Pharmaceuticals GAAP EPS of -$0.12 revenue of $3.22M November, 10 2022 04:24 PM Eton Pharmaceutcials Inc. Eton Pharmaceuticals press release ( NASDAQ: ETON ): Q3 GAAP EPS of -$0.12. Revenue of $3.22M (+312.8% Y/Y). For further details see: Eton Pharmaceuticals GAAP EPS of -$0.12, revenue of $3.22M